- Title
- TRLS-02. SAFETY AND EFFICACY OF BRAF INHIBITOR PLIXORAFENIB (FORE8394; PLX8394) IN CHILDREN AND ADULTS WITH RECURRENT, BRAF-ALTERED PRIMARY CENTRAL NERVOUS SYSTEM TUMORS (PCNST)
- Creators
- Macarena de la Fuente - University of MiamiNicholas A Butowski - University of California, San FranciscoJennie Taylor - University of California, San FranciscoRona Yaeger - Memorial Sloan Kettering Cancer CenterFrank Y-C Tsai - , Scottsdale, AZFilip Janku - The University of Texas MD Anderson Cancer CenterCarl E Allen - Texas Children's HospitalNatraj Ammakkanavar - Community Health NetworkGlenn Michelson - , Fairfax, CAPing Jiang - Integrated BioTherapeuticsEmil Samara - , San Marino, CAMichael Paz - Integrated BioTherapeuticsAlexia Tussay-Lindenberg - Integrated BioTherapeuticsKongming Wang - Integrated BioTherapeuticsStacie P Shepherd - Integrated BioTherapeuticsIrina Kline - Integrated BioTherapeuticsEric Sherman - Memorial Sloan Kettering Cancer CenterJordi Rodon - The University of Texas MD Anderson Cancer Center
- Publication Details
- Neuro-oncology (Charlottesville, Va.), Vol.26(Suppl 4), pp.0-0
- Publisher
- Oxford University Press
- Academic Unit
- Miller School of Medicine; UMMG Department of Neurology; UMMG Dept of Neurology - Neuro-Oncology Div
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991032064020802976
Journal article
TRLS-02. SAFETY AND EFFICACY OF BRAF INHIBITOR PLIXORAFENIB (FORE8394; PLX8394) IN CHILDREN AND ADULTS WITH RECURRENT, BRAF-ALTERED PRIMARY CENTRAL NERVOUS SYSTEM TUMORS (PCNST)
Neuro-oncology (Charlottesville, Va.), Vol.26(Suppl 4), pp.0-0
2024-06-18
Metrics
1 Record Views